🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11333+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11333 recruiting trials

Phase 2RecruitingNCT06375005

Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis

👨‍⚕️ JING XUE, PhD, Second Affiliated Hospital, School of Medicine, Zhejiang University📍 9 sites📅 Started Jan 2025View details ↗
NARecruitingNCT06675344

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

👨‍⚕️ Robyn T Domsic, MD, University of Pittsburgh📍 4 sites📅 Started Jan 2025View details ↗
Enrolling by InvitationNCT06958042

The Prevalence of Lower Urinary Tract Symptoms in Individuals With Chronic Obstructive Pulmonary Disease

🏥 Kutahya Health Sciences University📍 1 site📅 Started Jan 2025View details ↗
NARecruitingNCT06614270

Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Jan 2025View details ↗
Phase 4RecruitingNCT06754371

Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage

👨‍⚕️ Jie Xiao, PHD, Renji Hospital, Shanghai Jiaotong University, School of Medcine📍 1 site📅 Started Jan 2025View details ↗
NARecruitingNCT06158529

High-frequency SCS Versus SCS in the Treatment of Diabetic Peripheral Neuropathic Pain

👨‍⚕️ BiFa Fan, master, China-Japan Friendship Hospital📍 1 site📅 Started Jan 2025View details ↗
Phase 3RecruitingNCT06882564

Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.

👨‍⚕️ NOOR AA TAHER, B.D.S, Al-Mustansiriyah University📍 1 site📅 Started Jan 2025View details ↗
NARecruitingNCT06012760

The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Jan 2025View details ↗
NARecruitingNCT06426706

TPVB or SPSIPB in Pain Management After VATS

👨‍⚕️ Kamil Darçın, MD, Koç University📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06694792

Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium

🏥 IRCCS San Raffaele📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06504459

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

👨‍⚕️ Curtis A Lachowiez, OHSU Knight Cancer Institute📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06849635

Cera™ ASD Occluder Post-Market Clinical Follow-Up Study

🏥 Lifetech Scientific (Shenzhen) Co., Ltd.📍 6 sites📅 Started Jan 2025View details ↗
EARLY_Phase 1RecruitingNCT06775912

Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases

🏥 Nanjing Bioheng Biotech Co., Ltd.📍 1 site📅 Started Jan 2025View details ↗
Phase 1RecruitingNCT06710223

Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab

👨‍⚕️ Adam Burgoyne, MD, PhD, University of California, San Diego📍 1 site📅 Started Jan 2025View details ↗
Phase 1, PHASE2RecruitingNCT07017725

A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia

👨‍⚕️ Junping Chen, CASI pharmaceutical, Inc📍 6 sites📅 Started Jan 2025View details ↗
NAEnrolling by InvitationNCT07177378

Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure

🏥 Tanta University📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06851247

GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.

🏥 Sun Yat-sen University📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06745622

Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria

🏥 Haisco Pharmaceutical Group Co., Ltd.📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06737913

HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma

🏥 Sun Yat-sen University📍 1 site📅 Started Jan 2025View details ↗
Phase 1RecruitingNCT06710717

Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)

🏥 National University of Malaysia📍 1 site📅 Started Jan 2025View details ↗
← PreviousPage 179 of 567Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →